MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 197 filers reported holding MYRIAD GENETICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $666,590 | -72.3% | 41,558 | -60.0% | 0.00% | -100.0% |
Q2 2023 | $2,408,194 | +53.5% | 103,891 | +53.9% | 0.00% | 0.0% |
Q1 2023 | $1,568,466 | +263.1% | 67,519 | +126.8% | 0.00% | – |
Q4 2022 | $432,021 | +10.2% | 29,774 | +44.8% | 0.00% | – |
Q3 2022 | $392,000 | -78.6% | 20,567 | -71.7% | 0.00% | – |
Q1 2022 | $1,832,000 | +214.2% | 72,714 | +244.6% | 0.00% | – |
Q4 2021 | $583,000 | -11.5% | 21,102 | +3.4% | 0.00% | – |
Q3 2021 | $659,000 | -57.5% | 20,400 | -59.8% | 0.00% | – |
Q2 2021 | $1,550,000 | +108.9% | 50,700 | +108.1% | 0.00% | – |
Q1 2021 | $742,000 | -59.8% | 24,366 | -73.9% | 0.00% | -100.0% |
Q4 2020 | $1,847,000 | +99.2% | 93,384 | +31.4% | 0.00% | – |
Q3 2020 | $927,000 | +5.2% | 71,054 | -8.7% | 0.00% | – |
Q2 2020 | $881,000 | -23.3% | 77,795 | +84.7% | 0.00% | -100.0% |
Q4 2019 | $1,148,000 | +91.7% | 42,129 | +101.5% | 0.00% | +100.0% |
Q3 2019 | $599,000 | +87.8% | 20,910 | +81.8% | 0.00% | 0.0% |
Q2 2019 | $319,000 | +4.2% | 11,500 | +11.0% | 0.00% | 0.0% |
Q1 2018 | $306,000 | -18.2% | 10,364 | -28.3% | 0.00% | 0.0% |
Q2 2017 | $374,000 | +29.4% | 14,458 | +3.1% | 0.00% | 0.0% |
Q3 2016 | $289,000 | -71.5% | 14,029 | -40.2% | 0.00% | -83.3% |
Q4 2015 | $1,013,000 | +111.5% | 23,461 | +83.7% | 0.01% | +100.0% |
Q3 2015 | $479,000 | +5.3% | 12,770 | -4.1% | 0.00% | -40.0% |
Q1 2014 | $455,000 | – | 13,318 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |